ArticleClinical pharmacokinetics2022
Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases.
Ying Fei Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.